Urumin

Urumin is a peptide that was discovered in 2017 by researchers at the Emory University. It is found in the skin secretions of the Indian frog Hydrophylax bahuvistara, and has been found to have potent antiviral properties against the Influenza A virus.

Discovery

Urumin was discovered by a team of researchers led by Joshy Jacob at Emory University. The team was investigating the antimicrobial properties of peptides found in the skin secretions of different frog species. They discovered that Urumin, one of the peptides found in the skin secretions of Hydrophylax bahuvistara, had potent antiviral properties against the Influenza A virus.

Mechanism of Action

Urumin works by targeting the hemagglutinin protein on the surface of the Influenza A virus. Hemagglutinin is responsible for the virus's ability to bind to and enter host cells. Urumin binds to the hemagglutinin protein, preventing the virus from entering host cells and thereby inhibiting its ability to cause infection.

Potential Applications

The discovery of Urumin's antiviral properties has potential applications in the development of new antiviral drugs for the treatment of Influenza A virus infections. However, further research is needed to determine the safety and efficacy of Urumin in humans.

See Also

• Antiviral drug
• Influenza A virus
• Peptide
• Hemagglutinin

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!